Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials.
Saved in:
| Title: | Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials. |
|---|---|
| Authors: | Lanini, Simone1 (AUTHOR), Ioannidis, John P A1,2,3 (AUTHOR), Vairo, Francesco1 (AUTHOR), Pletschette, Michel4 (AUTHOR), Portella, Gina5 (AUTHOR), Di Bari, Virginia1 (AUTHOR), Mammone, Alessia1 (AUTHOR), Pisapia, Raffaella1 (AUTHOR), Merler, Stefano6 (AUTHOR), Nguhuni, Boniface7 (AUTHOR), Langer, Martin5 (AUTHOR), Di Caro, Antonino1 (AUTHOR), Edwards, Sarah J L8 (AUTHOR), Petrosillo, Nicola1 (AUTHOR), Zumla, Alimuddin1,9,10 (AUTHOR), Ippolito, Giuseppe1 (AUTHOR) giuseppe.ippolito@inmi.it |
| Source: | Lancet Infectious Diseases. Dec2019, Vol. 19 Issue 12, pe444-e451. 8p. |
| Database: | Academic Search Ultimate |
| ISSN: | 14733099 |
|---|---|
| DOI: | 10.1016/S1473-3099(19)30284-1 |
